| 18/01 | Pharming N : Bank of America Corporation - Pharming Group N.V. - Leiden |  |
| 17/01 | Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden | |
| 12/01 | Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden | |
| 2022 | Pharming announces positive interim analysis data from open-label extension study of le.. | |
| 2022 | Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden | |
| 2022 | Pharming announces positive interim analysis data from open-label extension study of le.. | |
| 2022 | Pharming Group N.V. Announces Positive Interim Analysis Data from Open-Label Extension .. | |
| 2022 | Pharming announces publication of data from Phase 3 Study of leniolisib in patients wit.. | |
| 2022 | Pharming Group N.V. Announces Positive Results of Phase 3 Clinical Trial of Investigati.. | |
| 2022 | Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden | |
| 2022 | Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden | |
| 2022 | Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden | |
| 2022 | Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden | |
| 2022 | Pharming Group Says European Medicines Agency Validates Marketing Authorization Applica.. | |
| 2022 | Pharming Group N.V. Announces European Medicines Agency Validates its Marketing Authori.. | |
| 2022 | Pharming N : Q3 2022 Financial Results Presentation | |
| 2022 | Pharming Group N.V. Reports Earnings Results for the Nine Months Ended September 30, 20.. | |
| 2022 | Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden | |
| 2022 | Pharming Group Seeks European Approval of Treatment for Rare Primary Immunodeficiency | |
| 2022 | Pharming Group N.V. Submits Marketing Authorisation Application to European Medicines A.. | |
| 2022 | Sector Update: Health Care Stocks Rally Premarket Wednesday | |
| 2022 | Pharming Group Says Application for Primary Immunodeficiency Drug Accepted for Priority.. | |
| 2022 | Pharming Group N.V. Announces US FDA Acceptance for Priority Review of its New Drug App.. | |
| 2022 | Pharming N : Halfjaarlijkse financiële verslaggeving | |
| 2022 | Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden | |
| 2022 | Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden | |
| 2022 | Point sur les fortes variations du jour : Marie Bri.. |  |
| 2022 | Pharming N : Group reports financial results for the first half of 2022 | |
| 2022 | Pharming Group N.V. Reports Earnings Results for the Half Year Ended June 30, 2022 | |
| 2022 | Pharming Group N.V. Announces Resignation of Robert Friesen, Chief Scientific Officer a.. | |
| 2022 | Pharming N : H1 2022 Financial Results Presentation | |
| 2022 | Pharming Announces New ICD-10-CM Code for APDS, a Rare Primary Immunodeficiency | |
| 2022 | Pharming Group N.V. Receives Accelerated Assessment in Europe for Leniolisib for the Tr.. | |
| 2022 | Pharming N : Group to present at Jefferies Healthcare Conference 2022 | |
| 2022 | GIMV NV completed the acquisition of 20.87% stake in Bioconnection B.V. from Pharming G.. | |
| 2022 | Pharming Group's Immunodeficiency Disease Drug Receives 'Promising Innovative Medicine'.. | |
| 2022 | Pharming Receives Agreement of Paediatric Investigation Plan and Promising Innovative M.. | |
| 2022 | Gimv Invests In Contract Development Group BioConnection | |
| 2022 | GIMV NV reached an agreement to acquire 20.87% stake in Bioconnection B.V. from Pharmin.. | |
| 2022 | Pharming Reports Data on Leniolisib Trial to Treat Rare Immunodeficiency | |
| 2022 | Pharming Group N.V. Announces Positive Data from Phase II/III Leniolisib Trial Presente.. | |
| 2022 | Pharming Group N.V. Reports Earnings Results for the Full Year Ended December 31, 2021 | |
| 2022 | Pharming N : Group Notice of 2021 Full Year Results | |
| 2022 | Pharming Group N.V. Announces Positive Results of Phase II/III Pivotal Clinical Study o.. | |
| 2022 | Pharming Receives Positive European Medicines Agency Decision on Paediatric Investigati.. | |
| 2022 | Pharming Group and Sanofi Renew Strategic Manufacturing Partnership Agreement | |
| 2021 | Sanofi : partnenariat renouvelé avec le néerlandais Pharming | |
| 2021 | Pharming Group, Sanofi Renew Strategic Manufacturing Partnership Agreement | |
| 2021 | Pharming Group and Sanofi Renew Strategic Manufacturing Partnership Agreement | |
| 2021 | Pharming Group reports financial results for the first nine months of 2021 | |
| 2021 | Pharming Group N.V. Provides Earnings Guidance for the Year 2021 | |
| 2021 | Pharming N : Pharming Group Notice of 9M Results | |
| 2021 | Pharming N : Group Notice of 9M Results | |
| 2021 | JPMorgan opens South Korea commercial banking office in international expansion | |
| 2021 | Pharming N : Pharming announces results from clinical trials for the treatment of COVID-19.. | |
| 2021 | Pharming N : announces results from clinical trials for the treatment of COVID-19 with RUC.. | |
| 2021 | Pharming Announces Results from Clinical Trials for the Treatment of COVID-19 with RUCO.. | |
| 2021 | Pharming to Seek Acquisitions | |
| 2021 | Pharming N : Group reports financial results for the first half of 2021 | |
| 2021 | Sign Up Now : Pharming's Half Year Financial Results Webinar | |
| 2021 | Pharming N : signs agreement with NewBridge Pharmaceuticals for the commercialization of R.. | |
| 2021 | Pharming Signs Agreement with Newbridge Pharmaceuticals for the Commercialization of Ru.. | |
| 2021 | Orchard Therapeutics : to Collaborate With Pharming Group on Treatm.. | |
| 2021 | Pharming N : Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and.. | |
| 2021 | Orchard Therapeutics : and Pharming Group Announce Collaboration to Develop and Commercial.. | |
| 2021 | Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercia.. | |
| 2021 | Orchard Therapeutics plc announced that it expects to receive $7.5 million in funding f.. | |
| 2021 | Pharming N : Pharming announces completion of enrolment in Phase II/III study with lenioli.. | |
| 2021 | Pharming N : announces completion of enrolment in Phase II/III study with leniolisib for a.. | |
| 2021 | Pharming Group N.V Announces Completion of Enrolment in Phase II/III Study with Lenioli.. | |
| 2021 | Pharming Group N.V.(ENXTAM:PHARM) added to Netherlands ASCX A.. | |
| 2021 | Pharming N : appoints Anurag Relan as Chief Medical Officer and Robert Friesen as Chief Sc.. | |
| 2021 | Pharming Group N.V. Announces Executive Changes | |
| 2021 | Pharming Group N.V.(ENXTAM:PHARM) dropped from AMX Index | |
| 2021 | Pharming N : announces the reimbursement of RUCONEST® in Spain | |
| 2021 | Pharming N : Group to present at Jefferies Virtual Healthcare Conference | |
| 2021 | Pharming Group N.V. Announces Executive Changes | |
| 2021 | Pharming Group N.V. Reports Earnings Results for the First Quarter Ended March 31, 2021 | |
| 2021 | Pharming N : Group reports financial results for the first quarter of 2021 | |
| 2021 | Pharming Group N.V. : des résultats sans saveur | |
| 2021 | Pharming Group N.V Announces Enrolment of First Patient in Multicentre Phase IIb Clinic.. | |
| 2021 | Pharming Group N.V. Announces Board Changes | |
| 2021 | Pharming N : Phishing, Pharming, Malware, And Other Internet Delights | |
| 2021 | Pharming Group Seeks Acquisitions | |
| 2021 | Pharming Group N.V. Reports Earnings Results for the Full Year Ended December 31, 2020 | |
| 2021 | Pharming Group N.V. Provides Earnings Guidance for the Remainder of 2021 | |
| 2021 | Pharming N : Group, in collaboration with Invitae Corporation, launches genetic testing pr.. | |
| 2021 | Pharming Group N.V. in Collaboration with Invitae Corporation, Launches Genetic Testing.. | |
| 2020 | Pharming Group N.V.(NasdaqGM:PHAR) added to NASDAQ Composit.. | |
| 2020 | Pharming N : Group announces ADSs admitted to trade on Nasdaq under the symbol “PHAR.. | |
| 2020 | Pharming N : Announces Instructions for Exchanging Listed Ordinary Shares into Nasdaq List.. | |
| 2020 | Pharming N : Reports on Extraordinary General Meeting of Shareholders | |
| 2020 | Pharming Group N.V. Announces Board Appointments | |
| 2020 | Pharming N : announces enrolment of first patient in US clinical trial for the treatment o.. | |
| 2020 | Pharming Group N.V. Announces Enrolment of First Patient in US Clinical Trial for the T.. | |
| 2020 | Pharming N : Juergen Ernst to retire from Pharming's Board of Supervisory Directors after .. | |
| 2020 | Pharming Group N.V. Announces Management Changes | |
| 2020 | Pharming N : announces commitment to build a new downstream manufacturing facility for RUC.. | |
| 2020 | Pharming Group N.V. Announces Commitment to Build A New Downstream Manufacturing Facili.. | |
| 2020 | Pharming N : appoints Jeroen Wakkerman as Chief Financial Officer | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
